Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement

NCT04323566 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-Compulsive Disorder
Obsessive-Compulsive Behavior
Schizophrenia
Delusional Disorder
Brief Psychotic Disorder
Schizo Affective Disorder
Other Psychoses
Unspecified Psychosis

Interventions

DRUG: Rituximab

Sponsor

Uppsala University Hospital

Collaborators

[object Object]